The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries.

ABSTRACT: Aim: According to the results of the MASTRO I living systematic review and meta-analysis, use of the EmboTrap Revascularization^® Device in the treatment of acute ischemic stroke (AIS) results in higher rates of good functional outcomes (90-day modified Rankin Scale [mRS] 0-2) compared with use of the Trevo^® Retriever or the Solitaire™ Revascularization Device. The aim of this analysis was to assess the potential economic impact of achieving improved functional outcomes for three commonly used stent retrievers (SRs) in the treatment of AIS. Methods: An economic model with short-term and long-term costs, representing a healthcare system perspective was developed using a decision tree to simulate a cohort of 1000 hypothetical patients treated for AIS with m

SUBMITTER: Andersson T 

PROVIDER: S-EPMC11864083 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature